Case 11-5

 

Venus Cellular

 

Venus Cellular Limited (“Venus”) is the leading, worldwide provider of a wide variety of telecommunications equipment and services. Its telecommunications equipment and services enable its customers to send or receive virtually any type of voice or data transmission. Its customers include fixed line and wireless telecommunication operators, Internet service providers, governments, and businesses. Venus prepares its financial statements in accordance with International Financial Reporting Standards (IFRSs).

 

Consolidated Statement of Comprehensive Income

 

 

 

 

 

 

20X1

20X0

 

(US$ millions except per share data)

Revenues

16,419

15,305

Cost of sales

(10,629)

(9,539)

Gross profit

5,790

5,766

Administrative and selling expenses

(2,500)

(2,430)

Research and development costs

(1,804)

(1,863)

Operating income  current

1,486

1,473

Share-based payments (stock option plans)

(86)

(75)

Restructuring costs

(138)

(405)

Impairment of capitalized development

-

 

(130)

Gain on one time contractual settlement

161

 

-

 

Operating income

1,423

 

 

863

 

Interest expense

(273)

(283)

Interest income

153

 

131

Finance costs

(120)

(152)

Income from sale of assets

1,858

 

244

Income before tax and associates

3,161

 

955

Income tax expense

(114)

 

(45)

Share in net income (losses) of associates

(18)

 

(76)

Profit or loss

3,029

 

834

Dividends

(265)

 

(247)

Retained profit or loss

2,764

 

587

Other comprehensive income:

 

 

 

 

 

 

 

Cash flow hedges

17

 

20

 

 

Available for sale financial assets

(50)

 

25

 

 

Share of other comprehensive income of associates

13

 

5

 

 

Total comprehensive income for the year

 

2,744

 

637

 

 



 

 

 

 

 

Copyright 2010 Deloitte Development LLC

 

All Rights Reserved.



Case 11-5c: Venus Cellular

 

Page 2

 

 

 

Profit or loss for the year attributable to:

 

 

Owners of the parent

1,951

537

Noncontrolling interests

1,078

297

Basic earnings per share (in US$)

3.76

1.49

Diluted earnings per share (in US$)

3.76

1.49

 

Required:

 

      Question 1 — Identify whether the analysis of expenses in profit or loss is presented by nature or function.

 

      Question 2 — Identify the alternative performance (operating) measures presented in the statement of comprehensive income and document your conclusions with regard to the appropriateness of the various performance measures.

 

      Question 3 — Discuss any additional issues you have identified or other observations.

    • 8 years ago
    A++ ANSWER

    Purchase the answer to view it

    blurred-text
    • attachment
      venus_cellular.doc